Compare SIGA & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIGA | HRZN |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 341.0M | 286.0M |
| IPO Year | 2016 | N/A |
| Metric | SIGA | HRZN |
|---|---|---|
| Price | $4.69 | $4.38 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 497.5K | ★ 813.6K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | 13.24% | ★ 33.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.25 |
| Revenue Next Year | $224.81 | $22.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.10 | $3.80 |
| 52 Week High | $9.62 | $8.46 |
| Indicator | SIGA | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 56.57 |
| Support Level | $4.29 | $3.93 |
| Resistance Level | $4.86 | $4.65 |
| Average True Range (ATR) | 0.19 | 0.16 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 71.52 | 79.51 |
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.